Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Douglas A. McIntyre | Jul 21, 2008 at 4:20 PM EDT

Merck Visits The Proctologist (MRK)

Merck & Co. (NYSE: MRK) posted earnings that look pretty good on the surface. The problem is that the surface…

Douglas A. McIntyre | Jul 16, 2008 at 7:42 AM EDT

ERBITUX Gets Approved in Japan for Colorectal Cancer (IMCL, BMY)

ImClone Systems Incorporated (NASDAQ: IMCL) has just announced that ERBITUX(R) has received marketing authorization in Japan for use in treating…

Douglas A. McIntyre | Jul 14, 2008 at 3:12 PM EDT

Genentech Masks a Whiff (DNA)

Genentech Inc. (NYSE: DNA) is initially looking like a severe disappointment to those who thought Cramer’s call last week was…

Douglas A. McIntyre | Jul 14, 2008 at 12:37 PM EDT

Genentech Ready to Lead Biotech Earnings Bias (DNA, BIIB)

Genentech Inc. (NYSE: DNA) is set to report earnings after the close of trading today. The largest biotech in the…

Douglas A. McIntyre | Jul 8, 2008 at 1:38 PM EDT

Long-Term Risks To Statin Sales? (MRK, PFE, AZN)

We have run a full feature story over at BioHealthInvestor.com after reading a study that came off the Mayo Clinic…

Douglas A. McIntyre | Jul 4, 2008 at 7:31 AM EDT

This Week’s BioHealth & Biotech Top Stories

We saw another exciting week full of news for key developments in drug stocks, biotech stocks, medical device stocks, and…

Douglas A. McIntyre | Jul 2, 2008 at 6:17 AM EDT

IPO FILING: ZONARE MEDICAL SYSTEMS (ZONE)

ZONARE MEDICAL SYSTEMS, INC. has filed for an initial public offering to sell up to $86.25 million as the nominal…

Douglas A. McIntyre | Jul 2, 2008 at 5:51 AM EDT

IPO FILING: Alimera Sciences, Inc. (ALIM)

A company called Alimera Sciences, Inc. has filed for an initial public offering to sell up to $75 million as…

Douglas A. McIntyre | Jul 2, 2008 at 5:26 AM EDT

UnitedHealth Guidance Tanks Again (UNH)

UnitedHealth Group (NYSE:UNH) is again lowering its guidance. The company now sees $2.95 to $3.05 EPS on revenues of around…

Douglas A. McIntyre | Jun 30, 2008 at 4:42 AM EDT

The Whining From Drug Companies: The FDA Is Hard On Us

The profit-mongering Big Pharma companies don’t want the FDA to take so long approving their drugs. It cuts into profits…

Douglas A. McIntyre | Jun 26, 2008 at 8:03 AM EDT

Sequenom Holds Up Well On Secondary Offering (SQNM)

Sequenom, Inc. (NASDAQ: SQNM) has priced its public secondary offering of 5,500,000 shares of common stock at a price of…

Douglas A. McIntyre | Jun 24, 2008 at 3:55 PM EDT

StemCells Shelf Filing Seems Almost ‘Re-IPO’ (STEM)

StemCells Inc. (NASDAQ: STEM) has filed a mixed securities shelf registration that will allow the company to raise up to…

Douglas A. McIntyre | Jun 14, 2008 at 7:31 AM EDT

The Week’s Top BioHealth Issues For Next Week (PFE, TEVA, CRA, IVGN, CMED, ANPI, ISRG, VVUS, CELG)

One key stock to watch next week is Pfizer Inc. (NYSE: PFE). While it has been in the land of…

Douglas A. McIntyre | Jun 9, 2008 at 4:38 PM EDT

Peplin Withdraws US IPO

An Australian company called Peplin Inc., which originally filed to come public in August 2007, has filed with the SEC…

Douglas A. McIntyre | Jun 7, 2008 at 6:01 AM EDT

The Week’s Top Biotech Movers For Next Week (TRCA, ACOR, ISPH, ONCY, PCYC, SQNM, IDEV, LGND, AUXL)

Out of the daily movers this last week, many of the top winners and losers were from news in many…

1 … 349 350 351 352 353 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Merck Visits The Proctologist (MRK)

ERBITUX Gets Approved in Japan for Colorectal Cancer (IMCL, BMY)

Genentech Masks a Whiff (DNA)

Genentech Ready to Lead Biotech Earnings Bias (DNA, BIIB)

Long-Term Risks To Statin Sales? (MRK, PFE, AZN)

This Week’s BioHealth & Biotech Top Stories

IPO FILING: ZONARE MEDICAL SYSTEMS (ZONE)

IPO FILING: Alimera Sciences, Inc. (ALIM)

UnitedHealth Guidance Tanks Again (UNH)

The Whining From Drug Companies: The FDA Is Hard On Us

Sequenom Holds Up Well On Secondary Offering (SQNM)

StemCells Shelf Filing Seems Almost ‘Re-IPO’ (STEM)

The Week’s Top BioHealth Issues For Next Week (PFE, TEVA, CRA, IVGN, CMED, ANPI, ISRG, VVUS, CELG)

Peplin Withdraws US IPO

The Week’s Top Biotech Movers For Next Week (TRCA, ACOR, ISPH, ONCY, PCYC, SQNM, IDEV, LGND, AUXL)

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Rivian Tops Q1 Estimates, but Investors Investors Rightly Remain Wary

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Health and Healthcare Articles

All Health and Healthcare Articles

Merck Visits The Proctologist (MRK)

ERBITUX Gets Approved in Japan for Colorectal Cancer (IMCL, BMY)

Genentech Masks a Whiff (DNA)

Genentech Ready to Lead Biotech Earnings Bias (DNA, BIIB)

Long-Term Risks To Statin Sales? (MRK, PFE, AZN)

This Week’s BioHealth & Biotech Top Stories

IPO FILING: ZONARE MEDICAL SYSTEMS (ZONE)

IPO FILING: Alimera Sciences, Inc. (ALIM)

UnitedHealth Guidance Tanks Again (UNH)

The Whining From Drug Companies: The FDA Is Hard On Us

Sequenom Holds Up Well On Secondary Offering (SQNM)

StemCells Shelf Filing Seems Almost ‘Re-IPO’ (STEM)

The Week’s Top BioHealth Issues For Next Week (PFE, TEVA, CRA, IVGN, CMED, ANPI, ISRG, VVUS, CELG)

Peplin Withdraws US IPO

The Week’s Top Biotech Movers For Next Week (TRCA, ACOR, ISPH, ONCY, PCYC, SQNM, IDEV, LGND, AUXL)

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Rivian Tops Q1 Estimates, but Investors Investors Rightly Remain Wary

Featured Reads

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts